Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 7245947, 4 pages
http://dx.doi.org/10.1155/2016/7245947
Clinical Study

The Initial Assessment of Daily Insulin Dose in Chinese Newly Diagnosed Type 2 Diabetes

Department of Endocrinology and Metabolism, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, No. 1630 Dongfang Road, Shanghai 200127, China

Received 22 March 2015; Revised 27 May 2015; Accepted 27 May 2015

Academic Editor: Raffaele Marfella

Copyright © 2016 Jing Ma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Xu, L. Wang, J. He et al., “Prevalence and control of diabetes in Chinese adults,” The Journal of the American Medical Association, vol. 310, no. 9, pp. 948–959, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. C.-Z. Wu, D. Pei, A.-T. Hsieh et al., “Comparison of insulin sensitivity, glucose sensitivity, and first phase insulin secretion in patients treated with repaglinide or gliclazide,” Archives of Pharmacal Research, vol. 33, no. 3, pp. 411–416, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Hu, L. Li, Y. Xu et al., “Short-term intensive therapy in newly diagnosed type 2 diabetes partially restores both insulin sensitivity and β-cell function in subjects with long-term remission,” Diabetes Care, vol. 34, no. 8, pp. 1848–1853, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Weng, Y. Li, W. Xu et al., “Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial,” The Lancet, vol. 371, no. 9626, pp. 1753–1760, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Wainstein, M. Metzger, M. Boaz et al., “Insulin pump therapy vs. multiple daily injections in obese type 2 diabetic patients,” Diabetic Medicine, vol. 22, no. 8, pp. 1037–1046, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Grunberger, T. S. Bailey, A. J. Cohen et al., “Statement by the American Association of Clinical Endocrinologists consensus panel on insulin pump management,” Endocrine Practice, vol. 16, no. 5, pp. 746–762, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Walsh, R. Roberts, and T. Bailey, “Guidelines for insulin dosing in continuous subcutaneous insulin infusion using new formulas from a retrospective study of individuals with optimal glucose levels,” Journal of Diabetes Science and Technology, vol. 4, no. 5, pp. 1174–1181, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Mu and S. Yin, “Insulin pump therapy guidelines for China (July 2010),” Journal of Diabetes, vol. 4, no. 2, pp. 127–139, 2012. View at Publisher · View at Google Scholar
  9. A. Kuroda, H. Kaneto, T. Yasuda et al., “Basal insulin requirement is ~30% of the total daily insulin dose in type 1 diabetic patients who use the insulin pump,” Diabetes Care, vol. 34, no. 5, pp. 1089–1090, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. Y.-L. An, Y. Gao, Q. Zhu et al., “Features of insulin secretion and insulin resistance in newly diagnosed type 2 diabetes of different body mass indices,” Zhonghua Yi Xue Za Zhi, vol. 89, no. 16, pp. 1117–1121, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Prentki and C. J. Nolan, “Islet beta cell failure in type 2 diabetes,” The Journal of Clinical Investigation, vol. 116, no. 7, pp. 1802–1812, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. E. S. Moghissi, M. T. Korytkowski, M. DiNardo et al., “American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control,” Diabetes Care, vol. 32, no. 6, pp. 1119–1131, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. J. N. Fisher, M. N. Shahshahani, and A. E. Kitabchi, “Diabetic ketoacidosis: low-dose insulin therapy by various routes,” The New England Journal of Medicine, vol. 297, no. 5, pp. 238–241, 1977. View at Publisher · View at Google Scholar · View at Scopus
  14. W. Yang, J. Liu, Z. Shan et al., “Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomised trial,” The Lancet Diabetes and Endocrinology, vol. 2, no. 1, pp. 46–55, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. W. Yang, J. Lu, J. Weng et al., “Prevalence of diabetes among men and women in China,” The New England Journal of Medicine, vol. 362, no. 12, pp. 1090–1101, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Fiallo-Scharer and The Diabetes Research in Children Network Study Group, “Eight-point glucose testing versus the continuous glucose monitoring system in evaluation of glycemic control in type 1 diabetes,” The Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 6, pp. 3387–3391, 2005. View at Publisher · View at Google Scholar · View at Scopus